LANGBAЯ ...... der 3 € thread - 500 Beiträge pro Seite

[B2L]

So, jetzt wird`s wirklich Zeit für nen neuen thread

dieser hier wird und zielsicher in den nächsten Wochen bis mind. 3 € führen
die Voraussetzungen sind gegeben - etwas Geduld ist noch gefragt


nachdem die Aktie (ehemals CROWN Corp. ) - aufgrund von Spekulationen - bis auf 0,126€ abgestraft wurde,
hat sie sich immo wieder bis auf 1,05 € erholt


ein Teil des Geldes wurde aus Brasilien nach Europa transferiert, auf den Rest warten wir noch

[B2L]

in den letzten Tagen gab es an der Londoner Börse kräftige Umsätze
hier haben sich def. etliche Fonds positioniert



die Zahlen für 2004 werden täglich erwartet, sowie die Ankündigung wie
das vorhandene Kapital investiert wird

die erwarteten news werden m.E. der Aktie locker über die 1,50 € hiefen


hier nochmal eine Empfehlung von Jan. 2005:

24.01.2005
Crown Corp. spekulativ kaufen
SmallCap Research

Die Experten von SmallCap Research bewerten die Aktie der Crown Corp. (ISIN BMG257441060/ WKN A0BKT3) mit " kaufen" .

Die Crown Corporation sei eine Beteiligungsgesellschaft, die sich auf Übernahmen von klein- bis mittelkapitalisierten Firmen spezialisiert habe. Der Interimsfinanzbericht der Gesellschaft zeige einen operativen Verlust von 1,37 Mio. Euro für den Zeitraum von Oktober 2003 bis März 2004. Seit dem Handel der Aktien am Londoner AIM habe Crown seine Strategie aktiv weiter entwickelt. Passende Unternehmen für Übernahmen durch eine Mehrheitsbeteiligung seien anvisiert worden. Dennoch sei das Unternehmen auch bereits jetzt hervorragend aufgestellt, um aus den Entwicklungen der osteuropäischen und insbesondere der russischen Märkte zu profitieren. Crown verfüge über exzellente Berater und durch die Bildung von separaten Tochtergesellschaften in den Bereichen Öl & Gas, Pharmazie und Immobilien sowie durch die Eröffnung von Büros in Moskau und St. Petersburg auch über eine solide Organisationsstruktur für eine erfolgreiche Geschäftstätigkeit in diesen Märkten.

Das von Crown Pharma ins Auge gefasste russische Pharmagroßhandelsunternehmen biete zusätzliche Wachstumsfantasie für die Crown Aktie. Die durchschnittliche jährliche Rate des Umsatzwachstums liege hier bei etwa 45%, die Nettogewinnmarge bei 150-300%. Der russische Pharmagroßhändler habe bereits Verträge für den Vertrieb seiner Produkte auf dem chinesischen, vietnamesischen, thailändischen und australischen Markt in Höhe von 238 Mio. Euro abgeschlossen. Für den US-Markt sei eine Absichtserklärung über den Vertrieb von Produkten in Höhe von 115 Mio. Euro unterzeichnet worden. Zudem werde die Produktion und Distribution neuer Bio-Regulatoren als Medikamente, biologisch aktive Nahrungsergänzungen und kosmetische Produkte vorangetrieben. Sollte die Übernahme zum Abschluss gebracht werden können, stehe eine Neubewertung des Pharmageschäfts von Crown an.

Anzeige

Die Crown-Aktie sei beim Börsengang im Oktober 2003 zu einem Preis von 5,00 Euro ausgegeben worden. Zurzeit befinde sie sich auf einem historischen Tiefststand bei 0,65 Euro. Mit dem aus dem Verkauf der Verträge in Argentinien zur Verfügung stehenden Assets in Höhe von rund 256 Mio. Euro notiere die Aktie bei knapp 70 Mio. ausstehenden Aktien mit einer Marktkapitalisierung, die ein Sechstel unter dem Buchwert des Unternehmens liege.

Die verfügbaren liquiden Mittel von Crown würden eine enorme Dimension für eine Aktie mit einer derart niedrigen Bewertung darstellen. Das Unternehmen sei absolut schuldenfrei. Der hohe Cash-Bestand des Unternehmens verdeutliche die krasse Unterbewertung der Crown-Aktie und sichere sie in Höhe des aktuellen Kurses deutlich ab. Die mittelfristigen Wachstumsaussichten würden gut erscheinen. Es könne davon ausgegangen werden, dass das Unternehmen in Kürze einige Übernahmen in Osteuropa abschließe. Sobald dies geschehe, sei es sehr wahrscheinlich, dass die Aktie von Crown einen deutlichen Kurssprung vollziehen werde.

Zusätzliches Kurspotenzial ergebe sich aus der Tatsache, dass Anlegern, die am 21.12.2004 im Besitz von Crown-Aktien gewesen seien, pro Aktie jeweils eine Aktie der Spin-Offs Crown Pharma und Crown Development zugeteilt worden sei. Für die Zukunft seien weitere Spin-Offs in Wachstumsbranchen geplant, bei denen bestehende Crown-Aktionäre mit Zusatzaktien der Tochtergesellschaften berücksichtigt würden. Anleger, die bei den derzeit günstigen Kursen zuschlagen würden, könnten so direkt an zukünftigen Aktivitäten der Crown Corporation partizipieren.

Die Experten von SmallCap Research empfehlen spekulativen Anlegern die Aktie der Crown Corp. zum Kauf, bei einem Kursziel von 2,50 Euro. Der Titel berge weiteres Kurspotenzial von bis zu 600% auf 3,90 Euro, wenn das Management seine Akquisitionsstrategie für 2005 konsequent umsetzen könne.

[B2L]

Kurs London




schön zu sehen die hohen Volumina der letzten Tage

[IrishTycoon]

UP TO DA MOON

[B2L]

Frankfurt







hier der link zur hp http://www.langbar.com/

[B2L]

servus @IT

ich sach nur bald .......

[IrishTycoon]

Langbar Realtime


http://www.weblayout.gmxhome.de/info.html

[B2L]

hier die heutigen trades in UK


http://www.advfn.com/p.php?pid=nmona&cb=1127407432&article=1…http://www.advfn.com/p.php?pid=trades&symbol=LSE%3ALGB&cb=11…

[B2L]

#8

oben auf trades klicken ....... dann sollte es klappen

[IrishTycoon]

[posting]17.998.343 von B2L am 22.09.05 18:52:32[/posting]Daran mußt du aber noch arbeiten

[B2L]

bis später


cu

[B2L]

[posting]17.998.368 von IrishTycoon am 22.09.05 18:54:35[/posting]da iss das Problem mit dem Passwort ..........

[pblack]

vielleicht schon morgen oder montag news

[Bandika]

Hallo,
genau diese beiden Tage wollte ich auch als wahrscheinlichen Tage für News angeben...das kann kein Zufall sein...

[IrishTycoon]

[posting]17.998.544 von pblack am 22.09.05 19:09:01[/posting]Am besten wieder vorbörslich

[alpine110]

nee, dann gibts wieder son doofes gap...

ähem, was erwartet ihr euch denn von den zahlen...?

[IrishTycoon]

[posting]18.000.404 von alpine110 am 22.09.05 20:46:33[/posting]äh, alpine wir erwarten nicht nur die Zahlen

[alpine110]

sondern?

geld is doch schon da. getan hat sich nich so viel (abgesehen von nem schönen tradinggewinn )

was kommt noch??

[B2L]

[posting]18.000.442 von IrishTycoon am 22.09.05 20:49:51[/posting]so ist es

- was passiert mit dem Geld, welche Investitionen werden getätigt
- wann wird das restliche Geld überwiesen



wie die Zahlen 2004 aussehen ......... das ist Kaffeesatzleserei

[B2L]

Stuart Pearson, Chief Executive, Langbar International commented:



" Moving our cash assets to Europe is a major step in the turnaround of the
Company. Whilst we have investigated a number of interesting opportunities in
South America, after discussions with our shareholders, we appreciate that they
would prefer to see the business develop primarily in Europe.

" I reiterate the Board`s commitment to growing the value of your Company, and in
the reduction of the wide discrepancy between our share price and our net asset
value. Our task in rebuilding Langbar has not always been helped by the spread
of rumour and false information, often taken out of context, which has been
disseminated through the `internet chat rooms`. We fully appreciate our
obligations to keep the Stock Market aware of significant events affecting
Langbar through a regulated information service. I would urge all our investors
to rely on these official releases from Langbar, rather than chat room gossip.

" Identifying and securing attractive investment opportunities, whether smallcap
businesses or property assets, will take time and your new management team are
fully committed to developing the investment strategy for the long term benefit
of shareholders.

" In only three months the Board has made significant progress, we have achieved
our first objective of releasing the funds and we have identified a number of
exciting opportunities, both large and small. I expect to be in a position to
make further announcements regarding potential investments shortly."


das war am 06.09.05

[B2L]

allaround...........

in dieser Aktie ist nicht nur extrem viel Fantasie

LGB hat erwiesenermaßen reichlich cash (über 3€/share) und wenn das Geld sinnvoll eingesetzt wird
sehen wir nächstes Jahr wieder die alten Höchststände


ich wünsche allen Investierten viel Glück

[B2L]

moin

ich denke das wir die RNS spätestens Mitte nächster Woche vorliegen haben

Stuart Pearson macht`s spannnend


geh. Stück in Lo erst 43 k
alle sind positioniert und warten

[B2L]

Berlin 0,92

[B2L]

ich schreibe hier mal ein paar Infos rein, die im Hauptthread ständig unter gehen

http://www.redmayne.co.uk/about_us/hitchin_lang_two.htm


Langbar International

Whenever there’s a suspension of trading on a share the bulletin board rumour mill winds itself up into a state of frenzy. If you’re a T-Trader suddenly looking at paying for your holding, there is nothing anyone can say to make the pain easier to bear. If you’re an Investor, having suspended stock is uncomfortable to say the least, but I will try to lay out the facts as I see them, following consultation with the company.

If there are any questions on this or would like help or information on this or any other stock market issue, please email me
Langbar’s History
Crown Corporation was a bombed out cash shell which had a tangled web of corporate actions including the flotation of Crown Pharmaceuticals, and an opaque deal concerning Argentinean construction contracts for promissory notes which it was thought unlikely to be honoured.

The History of Langbar International and Crown Corporation can be found on the bulletin boards. But up to the exercise of the Promissory Notes the history is, I think, largely irrelevant.

This First RNS statement on the 1st of June 2005 indicated that $350m had been paid into a Brazilian bank. This was the honouring of the Lambert Promissory note from Crown’s sale of Construction contracts, which had hitherto been thought unlikely. The share price of Crown Corporation jumped from 11p to 50p or so on the news.

On the 7th June, Crown released prelims up to December 2004 prelims up to December 2004. Dr. Mariusz Rybak was to be replaced as CEO by Stuart Pearson , who wanted a free hand and no interference from Rybak in return for circa 35% of the shares. Rybak waived the dividend due to him. These results summarised a series of corporate restructurings including the appointment of Arden Partners as brokers, Crown’s post balance-sheet take over of Langbar Capital, and the renaming of the company Langbar International. Also noted was the conversion of founder’s shares to Ords. Pearson had this to say about the company’s future plans for the cash:

"The Company is already looking at a number of interesting opportunities where profit and shareholder value can be significantly enhanced. Investments made are likely to have more of a UK focus and to be strong in assets where return on capital can be improved and ultimate shareholder value realised through trade sale or flotation."

In reality very little was said that wasn’t already in the public domain and the company languished at around 50p despite Pearson’s plea for the NAV of 240p to be taken into account. Clearly the market felt this smelt! There were hints that the Brazilian Government’s exchange controls might limit the scope for investment. Clearly they wanted this much dosh to stay at home!

Dr. Mariusz Rybak
Rybak’s position is interesting. Why was he given so much of the company? Clearly Pearson was not happy about it. Why did Rybak waive payments due to him? Why did he sell (he may have bought in the market in addition to the stake he was given) 20% of the company between this date and the Real Affinity Bid? It has since become clear that he was selling despite giving assurances to the Board that he was not.

The Cash
On the 30th June the company issued unequivocal statements concerning the presence of cash and the balance sheet of the audited accounts. In summary these are 144,496,118 fully diluted shares in issue following the issue of warrants Confirmation of the existence of the Term Deposits with the Banco Do Brazil from the auditors, who confirmed that $661,626,185 was sitting there, earning 7.5% per anum (260p per share, roughly). They also confirmed that there were no liabilities resulting from the sale of construction contracts to Lambert.

So at this point, with money in the bank, corporate structure in place and only one class of share, with a NAV of over £2, the shares were trading at below 50p. With increasing desperation and exasperation, Langbar issued further confirmation of the Cash situation on the 19th July Though problems with the access to the money were noted in the results, the prospect of a European Property asset swap (European Property Investment Company EPIC) for the term deposits is mentioned explicitly. Otherwise the cash would have to stay in Brazil.

The AGM statement on 25th July confirmed this, but there were hints (more obvious with the benefit of hindsight, naturally) that all is not well as far as access to the money and banking systems went, but they confirmed their NAV of 225p per share. The Market, reassured pushed the share price up to its highs of over 100p.

So Far So Good
This was the high water mark. Clearly something was wrong, and Lambert was selling. It was some of their 35% stake which were placed on 18th August at 48p, but several other institutions were brought on board in the placing. Pearson was clearly happy to have increased liquidity. (Incidentally, The designation “New Common Shares” refers to the capital reorganisation (previously there were founders and Ordinary shares) and does not mean that new capital was raised.) This did have the effect of increasing liquidity. 5% of the company was placed.

On the 6th September , another statement was released concerning the release of some of these assets from the bank of Brazil.

“Confirmation has been received that the cash deposits acquired from Crown pharmaceuticals Limited (US$294m) have been successfully transferred to a Langbar International head office account of ABN Amro BV in Holland, and has been admitted to the Euroclear and DTCC platforms (with the corresponding ISIN and CUSIP numbers). The interest rate on these deposits has been agreed at 3.5% p.a..”

The Market liked this and the share price jumped to a high of 88p.

On the 29th September, Langbar announced the acquisition of Real Affinity (RAF) for paper, 200 RAF shares per Langbar share. The plan is to recapitalise and refloat the company. Massive due diligence was not needed as Stuart Pearson was chairman of RAF….

So the situation was this:


$294m was in Holland earning 3.5%
This was earmarked unofficially for a European business transaction
The remaining $367m was on 7.5% term deposit in the Banko do Brazil..
This had by this stage been earmarked for a Portuguese and Spanish Property development, EPIC
Real Affinity was to be bought (RAF)
Shareholders were to realise their investment in shares in the form of a refloated RAF, EPIC one other profitable, cash generative investment
Up to $50m or so was to be retained in Langbar as capital for Pearson’s Corporate finance Boutique
There was to be no distribution of cash to shareholders
But the shares kept sliding…
The reasons became clear when the UK takeover rules forced Rybak to disclose his selling of his stake, once around 35% (possibly more) to just 19%. Secondly, several hedge funds who had acquired 10% of the stock at 30p and below had been pressuring Pearson for a distribution. They were selling at a profit and didn’t really mind the slide. One of the institutions who had been involved with the Placing at 48p also was selling.

There were buyers at 70p and below in early October, but the selling pressure was too great. Clearly some people had got wind that there were problems with the cash. Rumours began circulating which reappeared in the FT, and the Sunday Times concerning problems with the cash.

On the 12th October, Langbar requested a suspension “Pending Independent Verification of Certain Assets”. The Yorkshire Post and others suggested that these assets were the cash in ABN Amro, though the company denies that there is a problem with the money. The company requested a suspension (so they say) because Rybak’s selling had prompted a run on the shares and the rumour mill would up uncertainty. Better to have a definitive statement on the assets than watch the share price slide any further.

So where does that leave the unfortunate shareholder in Langbar?
Well, in conversation with the CEO of RAF, it was suggested that Pearson was not worried, and the RAF deal would go through on, or near schedule. As far as I’m aware, due diligence on the EPIC asset swap is ongoing and announcements to that end are still expected by November or soon after. The Financial PR firm have indicated that the rumours of missing money are just that: Rumours.

Pearson must have received confirmation from ABN Amro to issue this

Conclusion:
I’m confident that the money is there: there has been too much checking, and too many RNS statements confirming auditors’ (Gironella Velasco now part of Horwath) opinions. This is not complex SPV accounting. It is cash in a bank account. The company would “be very surprised if anything was found to be amiss”. Nevertheless a full audit is underway and that should finally clear the matter.

Whilst this does not represent a personal recommendation, which would reflect personal objectives, risk profile and circumstances, Real Affinity shares representing a proxy for the suspended Langbar might just be worth a punt for the investor with an appetite for risk